Sempra (SRE) — 2Q26 Earnings Preview

Company

Sempra Energy

Ticker

SRE (NYSE)

Reporting Period

2Q 2026 (quarter ended June 30, 2026)

Earnings Date

August 6, 2026 — 12:00 PM ET

Prepared

August 5, 2026

Last Earnings

May 7, 2026 (1Q26)

1. Earnings Preview

Key Takeaway: Setup is modestly constructive — the bar is achievable and the Q2 print should benefit from a one-time Oncor rate-case catch-up, but the stock has de-rated ~8% since last earnings and the SIP transaction close (expected Q3) is the real catalyst the market is waiting for.

Heading into the 2Q26 print, the most important dynamic is the recognition of Oncor's base rate review benefit — management explicitly flagged on the Q1 call that the positive financial impact from the April PUCT final order (higher authorized equity layer of 43.5%, ROE of 9.75%, cost of debt of 4.94%) would be primarily recognized in Q2, along with a surcharge covering the January 1 – June 1, 2026 period, making this quarter a structurally stronger earnings quarter than Q1. Consensus adjusted EPS sits at ~$1.06, well below the $1.51 reported in Q1 (which was seasonally strong), but the Oncor catch-up provides a visible tailwind that should help the company meet or modestly beat the bar. Estimate revisions have been broadly stable-to-slightly-higher since the Q1 print, with the July consensus at $1.07 vs. the $1.09 baseline set five days post-Q1 earnings, suggesting the street has not aggressively raised the bar. The stock has underperformed both XLU and the S&P 500 since May 7, declining from ~$91.57 to ~$84.66 (−7.6%) as of August 5, driven primarily by multiple compression rather than estimate cuts, leaving the setup less stretched than it was entering Q1. The key wildcard is the timing and financial terms of the Sempra Infrastructure Partners (SIP) sale — management guided Q2 or Q3 close, and any update on closing timeline, proceeds deployment, or rating agency threshold improvement could move the stock more than the EPS print itself.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus adjusted EPS of ~$1.06 for 2Q26 is a manageable bar, with the Oncor rate-case catch-up providing a visible Q2 tailwind. FFO/debt trajectory is the secondary swing factor as the market watches for credit metric improvement post-SIP close.

Table 1 — Current Quarter Snapshot (2Q26)

KPI

1Q26 Actual (Last Qtr)

2Q25 Actual (Prior Year)

2Q26 Consensus Estimate

YoY Change

FY26 Guidance

Consensus vs. Guidance Midpoint

Adjusted EPS (Diluted Operating)

$1.51

$0.89

$1.06

+19.0% YoY

$4.80–$5.30 (mid $5.05)

FY26 consensus $5.14 ≈ +1.8% above mid

Total Capital Expenditure

$1.84B

$2.79B

$2.39B

−14.3% YoY

~$9.4B FY26 (VA consensus)

N/A — no quarterly guidance

Oncor CapEx (Texas Utilities)

$876M

$485M

$2.03B

+318% YoY

~$6.0B FY26 (VA consensus)

N/A — no quarterly guidance

FFO / Total Debt (%)

15.5%

13.8%

14.2%

+40 bps YoY

~17.5% FY26 (VA consensus)

N/A — no quarterly guidance

Sources: Visible Alpha Consensus and Actuals Data (EPS — Diluted Operating, Total Capital Expenditure, Capital Expenditure – Texas Utilities/Oncor, FFO/Total Debt). 2Q26 consensus as of August 5, 2026. 2Q25 and 1Q26 actuals from Visible Alpha. FY26 guidance from SRE Q1 2026 earnings call (May 7, 2026).

Table 2 — Beat/Miss History: Adjusted EPS (Last 8 Quarters)

Quarter

Reported Adj. EPS

Consensus Est.

Surprise %

Result

1Q26

$1.51

$1.52

−0.7%

In-Line / Slight Miss

4Q25

$1.28

$1.19

+7.6%

Beat

3Q25

$1.11

$0.91

+21.9%

Beat

2Q25

$0.89

$0.85

+5.0%

Beat

1Q25

$1.44

N/A — not in VA

N/A

N/A

4Q24

N/A — not in VA

N/A — not in VA

N/A

N/A

3Q24

N/A — not in VA

N/A — not in VA

N/A

N/A

2Q24

N/A — not in VA

N/A — not in VA

N/A

N/A

Pattern: In the four quarters where VA data is available, SRE beat adjusted EPS consensus three times and was in-line/slight miss once (1Q26), suggesting a modest but consistent tendency to meet or exceed the bar. Source: Visible Alpha Consensus and Actuals Data.

3. Guidance & Commentary Evolution

Key Takeaway: Guidance is unchanged since the Q1 call — FY26 and FY27 EPS ranges were both affirmed, and the long-term 7–9% growth rate was reiterated. The only post-earnings corporate action was the CFO succession announcement (July 9), which is a transition event tied to the SIP close rather than a guidance revision.

Metric

Initial Guidance (Q1 2026 Call, May 7, 2026)

Revised Guidance

Current Consensus

Note

FY26 Adjusted EPS

$4.80 – $5.30

— Unchanged

$5.14

Affirmed on Q1 call; consensus sits ~$0.09 above midpoint

FY27 Adjusted EPS

$5.10 – $5.70

— Unchanged

$5.55

Affirmed on Q1 call; consensus near midpoint ($5.40)

Long-Term EPS Growth Rate

7% – 9% annually

— Unchanged

N/A

Reiterated as “one of the highest in the utility sector”

5-Year Capital Plan

$65B base plan (2026–2030)

— Unchanged

N/A

~$9B incremental opportunities flagged; Q2 update expected

Oncor Capital Plan

$47.5B base; $10B incremental identified

— Unchanged

N/A

Management committed to Q2 call update on firming incremental CapEx

SIP Transaction Close

Q2 or Q3 2026

Updated to Q3 2026 (July 9 8-K)

N/A

↑ CFO succession tied to SIP close; effective date TBD around Q3 close

SDG&E / SoCalGas 2028 GRC

Filing expected June 2026

Filed June 15, 2026 (8-K)

N/A

SDG&E requested $3,760M; SoCalGas $5,096M for 2028 test year; CPUC decision expected end-2027

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have been broadly stable since the Q1 print — 2Q26 EPS consensus drifted slightly lower (from $1.09 to $1.06) while FY26 and FY27 are essentially flat, suggesting the street is tracking guidance rather than diverging. No meaningful gap between consensus and guidance midpoints.

KPI (Period)

Estimate ~5 Days Post Q1 Earnings (as of 5/14/26)

Current Consensus (8/5/26)

Estimate Δ (%)

Initial Guidance (Q1 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance Mid (%)

Adj. EPS — 2Q26

$1.09

$1.06

−2.8%

No quarterly guidance

No quarterly guidance

N/A

N/A

Adj. EPS — FY26

$5.17

$5.14

−0.6%

$4.80 – $5.30 (mid $5.05)

Unchanged

0%

+1.8% above mid

Adj. EPS — FY27

$5.57

$5.55

−0.4%

$5.10 – $5.70 (mid $5.40)

Unchanged

0%

+2.8% above mid

Total CapEx — FY26

$4.30B

$9.43B

+119%

$65B 5-yr plan (~$13B/yr avg)

Unchanged

0%

N/A — annual plan not quarterly

FFO/Debt — FY26

19.5%

17.5%

−2.0 pp

No explicit guidance

No explicit guidance

N/A

N/A

Note: The large CapEx revision in the 5/14 vs. current column reflects a data methodology difference in how VA captures quarterly vs. annual CapEx estimates; the FY26 annual consensus of $9.4B is the more reliable figure. EPS estimates are stable and tracking guidance. Source: Visible Alpha Consensus and Actuals Data.

5. Stock Performance

Key Takeaway: SRE has underperformed both XLU and the S&P 500 since the Q1 print, declining ~7.6% vs. XLU −3.2% and SPY +5.2%, driven primarily by multiple compression (EV/EBITDA contracted ~6% over 1M and 3M) rather than estimate cuts. The de-rating reflects macro rate sensitivity and SIP transaction uncertainty, not fundamental deterioration.

Indexed Performance Since Last Earnings (May 7, 2026 = 100):

Date

SRE (Indexed)

XLU (Indexed)

SPY (Indexed)

May 7, 2026 (Base)

100.0

100.0

100.0

May 22, 2026

101.3

100.5

101.9

June 26, 2026 (Peak)

102.0

102.5

100.2

July 8, 2026

104.1

100.5

101.9

July 29, 2026

97.0

99.5

99.7

August 5, 2026

92.4

96.8

105.2

Key Events: June 15–16 — SDG&E/SoCalGas 2028 GRC filed (8-K). July 9 — CFO succession announced (Justin Bird to replace Karen Sedgwick upon SIP close). SRE peaked around July 8 at ~$95.33 before selling off ~11% into earnings. Sector ETF: XLU (Utilities Select Sector SPDR). Source: Stock Price Data (Yahoo Finance).

Performance Decomposition: Over the 1-month and 3-month windows, SRE's price decline of ~10.5% was driven primarily by EV/EBITDA multiple compression (−5.9% and −6.4% respectively), with the remainder attributable to earnings/estimate changes. The 12-month picture is more constructive: SRE is +2.1% with EV/EBITDA expanding +10.7%, suggesting the long-term re-rating thesis remains intact but near-term sentiment has turned cautious. Source: Stock Performance Decomposition Data.

6. Material News & Developments

Key Takeaway: The most important post-Q1 development is the CFO succession tied to the SIP close — a signal that the transaction is on track for Q3. The 2028 GRC filing is a long-dated but strategically significant event for California rate base growth.

7. Peer Commentaries / Read-Throughs (Last 60 Days — 2Q26 Current-Period Only)

Key Takeaway: Peer 2Q26 earnings are uniformly constructive on Texas/data center load growth and regulated utility earnings power, providing strong read-throughs for Oncor. California wildfire risk remains an idiosyncratic SRE overhang with no direct peer read-through. Note: All commentary below is from peers reporting on their own 2Q26 (current) period or forward outlook — no retrospective prior-quarter commentary is included.

A. Texas Load Growth & Data Center Demand

American Electric Power (AEP) — 2Q26 Earnings Release (July 30, 2026):

CenterPoint Energy (CNP) — 2Q26 Earnings Call (July 28, 2026):

Dominion Energy (D) — 2Q26 Earnings Call (July 31, 2026):

B. Regulated Utility Earnings & Capital Recovery

NextEra Energy (NEE) — 2Q26 Earnings (July 24, 2026):

PG&E (PCG) — 2Q26 Earnings (July 22, 2026):

Edison International (EIX) — 2Q26 Earnings (July 30, 2026):

C. Power Equipment & Grid Infrastructure

GE Vernova (GEV) — 2Q26 Earnings (July 22, 2026):

D. Sector-Level Themes Relevant to SRE

8. Insider Transaction Activity

Key Takeaway: Three open-market sales since the Q1 print, all relatively small in dollar terms. One was a pre-planned 10b5-1 sale (Chief Legal Counsel); the other two appear discretionary. No open-market buys. The absence of insider buying is not alarming given the stock's recent weakness, but the lack of any purchase signal is notable.

Name

Title

Transaction Type

Shares

Date

Note

Caroline Ann Winn

Executive Vice President

Open Market Sale

8,000 shares

June 17, 2026

Discretionary sale; ~25,164 shares remaining post-transaction

Pablo Ferrero

Director

Open Market Sale

2,600 shares

May 18, 2026

Discretionary sale; ~15,423 shares remaining post-transaction

Diana L. Day

Chief Legal Counsel

10b5-1 Planned Sale

3,300 shares

May 14, 2026

Pre-planned 10b5-1 sale; obligation-driven, not a discretionary signal

Source: SEC Form 4 Filings (Insider Transaction Data). Only open-market buys (code P) and sales (code S) included. No open-market purchases were filed in the period May 7 – August 5, 2026.

9. Key Risks & Questions for Management

Key Risks

Questions for Management

  1. SIP Transaction Update: Can you confirm the SIP close is on track for Q3 2026? What is the expected net proceeds to Sempra, and how will they be allocated between parent debt paydown and utility reinvestment? When do you expect rating agency threshold improvements to be formalized?
  2. Oncor Incremental CapEx: You committed to a Q2 call update on the ~$9B of incremental capital opportunities. How much of that $9B has now been firmed up, and what is the expected timing of incorporation into the base plan? Is there additional “I-squared” upside beyond the $9B?
  3. Oncor UTM & Rate Case Catch-Up: How much of the Oncor rate case benefit (surcharge for January 1 – June 1, 2026) was recognized in Q2? What is the expected quarterly run-rate benefit from the new authorized ROE and equity layer going forward?
  4. California Wildfire Legislation: What is your current assessment of the probability and timeline for wildfire liability reform in California? How are you engaging with the Governor's office and legislators? What is the financial exposure for SDG&E if no reform passes this session?
  5. SDG&E TO6 FERC Settlement: What is the expected financial impact of the TO6 settlement if approved (retroactive to June 1, 2025)? Is there any risk of FERC modifying the settlement terms?
  6. ECA LNG Phase 1: Has first LNG been produced? What is the current status of substantial completion, and when do you expect to begin recognizing LNG revenues from long-term contracted sales?
  7. FY26 Guidance Confidence: With H1 complete, can you narrow or raise the $4.80–$5.30 FY26 adjusted EPS guidance range? What are the key variables that could push you toward the high or low end?